RFK Jr. wants to eliminate FDA’s controversial food additive program. Here’s why that matters
It’s time to revamp the FDA’s “generally recognized as safe,” or GRAS, program that allows companies to add untested ...
ClickOnDetroit4d
CEO, 3 others charged after 5-year-old killed in Oakland County hyperbaric chamber explosion
Four Oxford Center employees, including the CEO and safety manager, have been charged in connection to the death of a ...
GlobalData on MSN4d
Former Magellan CEO pleads guilty in inaccurate lead tests case
Magellan Diagnostics’ former CEO Amy Winslow pleaded guilty on 11 March to concealing device malfunctions in the company’s LeadCare lead detection tests that led to inaccurately low blood lead level ...
BioSpace11d
FDA, Other Experts Seek to Redefine Obesity and Prioritize Maintenance Treatment
Two recent documents—one from the FDA, the other from a commission organized by The Lancet Diabetes & Endocrinology—indicate ...
ABC News4d
Compound versions of some weight loss drugs to be restricted
The FDA has declared the shortages as “resolved ... demand for the compounded versions of the drug,” Scott Brunner, CEO of Alliance for Pharmacy Compounding, another compounding industry ...
GlobalData on MSN5d
FDA clears Caristo’s AI-powered CAD diagnostic software
The software can determine the extent and severity of coronary plaque build-up implicated in coronary artery disease.
PharmExec4d
FDA Fast Track: Accelerating AlloNK's Development
Fred Aslan, MD, CEO, Artiva Biotherapeutics, explains what the FDA Fast Track designation for AlloNK in autoimmune diseases means for the acceleration of its development and potential approval of the ...
NC Biotech2d
Doron’s biologic osteoarthritis treatment gets FDA boost
Doron Therapeutics, a clinical-stage biotechnology company based in Chapel Hill, has received a Regenerative Medicine Advanced Therapy (RMAT) designation from the U.S. Food and Drug Administration ...